SoylentNews

upstart [soylentnews.org] writes:

████ # This file was generated bot-o-matically! Edit at your own risk. ████

just-one-more-dose-please

Pfizer submits data to FDA for authorization of Covid vaccine booster shot for general population [cnbc.com]:

Pfizer [cnbc.com] and BioNTech [cnbc.com] said Monday they have submitted early stage clinical trial data to the Food and Drug Administration as part of their U.S. application seeking authorization of a Covid vaccine booster for everyone 16 and older — not just people with weak immune systems.

In a phase one trial, a booster dose of the vaccine generated "significantly higher neutralizing antibodies" against the original coronavirus [cnbc.com] strain as well as the beta and delta variants, the companies said in a press release. Participants in the trial received a third shot of the two-dose vaccine about eight to nine months after receiving their second shot, they said.

"The data we've seen to date suggest a third dose of our vaccine elicits antibody levels that significantly exceed those seen after the two-dose primary schedule," Pfizer CEO Albert Bourla said in a statement. "We are pleased to submit these data to the FDA as we continue working together to address the evolving challenges of this pandemic."

The companies said late-stage trial results evaluating the third dose are expected shortly and will also be submitted to the FDA and other regulatory authorities worldwide.

Original Submission